Om Bioneer
Home
Products and Services
Drug Development
>
Characterization - small molecules
Characterization - biologics
Absorption - small molecules
Absorption - biologics
Formulation development - small molecules
Formulation development - biologics
Formulation characterization - small molecules
Formulations characterization - biologics
Biomarkers and Drug Targets
>
Biomarker and Drug Target Discovery
Biomarker and Drug Target Validation
Image Documentation and In Situ Visualization
Biomarker Assay Development
Molecular Methods, Tools and Equipment
Consultancy Assistance
Protein Manufacturing
>
L. lactis P170 protein production system
L. lactis process optimization
L. lactis contract production
E. coli protein production system
E. coli process optimization
E. coli contract production
Mammalian expression system
Mammalian expression optimisation
Mammalian cell based research
Mammalian contract production
Analytical scale protein purification
Analytical to gram scale purification
Gram scale purification
Documentation and quality systems
Production master document
cGMP compliant documentation
Immune Targeting
>
Human dendritic cell models
Murine dendritic dell models
PBMC models
Immune related cell line models
Active Ingredients and Microorganisms
>
Microbial strain optimization
Probiotic bacteria characterization package
Licensing Opportunities
Bioneer - your partner in biology
Client References
Research and Development
About us
Board and Management
Bioneer:FARMA
>
Bioneer:FARMA (In Danish)
Organization
Financials
Bioneer (In Danish)
GTS (In Danish)
>
Alexandra
AgroTech
Bioneer
DBI
Delta
DFM
DHI
FORCE Technology
Teknologisk institut
News
Newsletter
Newsletter Archive
>
Newsletter March 2010
P170 Archive
Newsletter Sign Up
Meet us at
Contact
News
New Article on Dendritic Cells Vaccines
See more here
PubMed
